» Articles » PMID: 27227519

The Clinical Characteristics and Predictors of Refractory Mycoplasma Pneumoniae Pneumonia in Children

Overview
Journal PLoS One
Date 2016 May 27
PMID 27227519
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To analyze the clinical characteristics of refracory Mycoplasma pneumoniae pneumonia (RMPP), and explore the related factors predicting RMPP.

Methods: Retrospective analysis was performed on 634 children with Mycoplasma pneumoniae pneumonia (MPP) hospitalized in our hospital between January 1, 2011 and December 31, 2014. The clinical features, laboratory data, radiological findings between the RMPP group and the general Mycoplasma pneumoniae pneumonia (GMPP) group were compared and the predictive values of related factors were analyzed.

Results: The median age of the RMPP patients (n = 145) was much older than that of the GMPP patients (n = 489) (P<0.01). We also found more severe presentations, higher incidence of extra-pulmonary complications and more serious radiological findings in RMPP group, which needed oxygen more often, longer antibiotics administration and intensive care (P<0.05). Meanwhile, the levels of C-reactive protein (CRP), lactic dehydrogenase (LDH), immunoglobulin A (IgM), interleukin (IL)-6, IL-10, interferon gamma (IFN-γ) and the percentage of neutrophils, CD8+ in RMPP group were significantly higher than those in GMPP group (P<0.05); while the levels of prealbumin (PAB) were lower than that in GMPP group (P<0.01). In ROC curve analysis, the percentage of neutrophil, CRP, LDH, PAB, IL-6, IL-10 and IFN-γ were useful for differentiating patients with RMPP from those with GMPP. Multiple logistic regression analysis showed that the CRP≥16.5mg/L, LDH ≥417IU/L and IL-6 ≥14.75pg/ml were significant predictors regarding to RMPP.

Conclusions: CRP≥16.5mg/L, LDH ≥417IU/L and IL-6 ≥14.75pg/ml might be the significant predictors of RMPP in children, which can aid in early recognition of RMPP.

Citing Articles

pneumonia in children.

Butpech T, Tovichien P World J Clin Cases. 2025; 13(5):99149.

PMID: 39959768 PMC: 11606359. DOI: 10.12998/wjcc.v13.i5.99149.


Comparison of thromboelastographic profiles and clinical characteristics in children with severe Mycoplasma pneumoniae pneumonia.

Li Y, Ma Y, Dai F, Peng Z, Dai Y, Zhi K Front Pediatr. 2025; 13:1459455.

PMID: 39911585 PMC: 11794201. DOI: 10.3389/fped.2025.1459455.


Clinical characteristics and risk factors for pneumonia in children.

Zhao X, Lv J, Wu M, Wu Q Front Pediatr. 2025; 12:1438631.

PMID: 39764167 PMC: 11701002. DOI: 10.3389/fped.2024.1438631.


Clinical characteristics and predictive indictors of macrolide-unresponsive pneumonia in children: a retrospective study.

Li Y, Liu Y, Chen X, Xiao X, Chen Y, Wang L Front Pediatr. 2024; 12:1489389.

PMID: 39691386 PMC: 11649403. DOI: 10.3389/fped.2024.1489389.


Risk association model for atelectasis complication in pneumonia patients following standardized treatment.

Xu M, Fan M, Wang H, Qian J, Jiang Y, Zhu Y Front Pediatr. 2024; 12:1422074.

PMID: 39670190 PMC: 11634606. DOI: 10.3389/fped.2024.1422074.


References
1.
Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E . Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med. 2008; 102(12):1762-8. DOI: 10.1016/j.rmed.2008.06.022. View

2.
Cao B, Zhao C, Yin Y, Zhao F, Song S, Bai L . High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010; 51(2):189-94. DOI: 10.1086/653535. View

3.
Khan F, Yassin M . Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature review. Braz J Infect Dis. 2009; 13(1):77-9. DOI: 10.1590/s1413-86702009000100018. View

4.
Radisic M, Torn A, Gutierrez P, Defranchi H, Pardo P . Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis. 2000; 31(6):1507-11. DOI: 10.1086/317498. View

5.
Socan M, Ravnik I, Bencina D, Dovc P, Zakotnik B, Jazbec J . Neurological symptoms in patients whose cerebrospinal fluid is culture- and/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin Infect Dis. 2001; 32(2):E31-5. DOI: 10.1086/318446. View